ConSynance Therapeutics
PrivateLast Round
Grant
Apr 15, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ConSynance Therapeutics is a biopharmaceutical company that develops treatments for central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ConSynance Therapeutics Comparables
Compare ConSynance Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Saniona AB | 78% | |
| Aardark Therapeutics | 77% | |
| Relmada Therapeutics | 74% | |
ConSynance Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 15, 2026 | ||||
| Divestiture | Aug 9, 2021 |
ConSynance Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foundation for Prader-Willi Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Received grant from Foundation for Prader-Willi Research.
- Mar 1, 2026
Monthly visitors grew 570% MoM to 1.5K.
ConSynance Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ConSynance Therapeutics's valuation, stock price, and market status.